12:00 AM
Dec 17, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Mdm4 p53 binding protein homolog (MDM4; MDMX)


INDICATION: Cancer; lymphoma

In vitro, patient sample and mouse studies suggest antisense oligonucleotides targeting MDM4 exon 6 could help treat cancer. Human melanoma, ovarian, breast, and other cancer cell lines and melanoma tumor samples from patients expressed high levels of full-length MDM4 and low levels of an...

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >